T. C. Gauler - Westdeutsch Tumorzentrum, Univ Duisburg Essen

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 57 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

1988MO Recruitment discontinuation in TREASURE trial (thoracic radiotherapy with atezolizumab in small cell lung cancer extensive disease) due to unexpected safety data

F. Bozorgmehr, F. Weykamp, T.R. Overbeck, N. Maguire, E.L. Buchmeier, M. Hammer-Hellmig,T.C. Gauler, M. Wermke, E.G.C. Troost, M. Ulmer,A-C. Mueller,K. Kokowski,

Annals of Oncology (2023): S1060-S1060

引用0浏览0引用

927P Patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab (NIVO) in the first-line (1L) or later-line (2L+) settings in Germany: Updated results from the real-world HANNA study

B. Kubuschok,E. von der Heyde, D.A. Hahn, C. Langer, U. Bockmühl,H. Mueller-Huesmann, G. Klautke,P-S. Mauz, B. Reuter,J. von der Grün, D. Beutner, J. Büntzel,

Annals of Oncology (2023): S584-S585

引用0浏览0引用

HANNA: Real-world data of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN), including first-line population, treated with nivolumab in Germany

C. Langer,E. von der Heyde, D. A. Hahn, B. Kubuschok, U. Bockmuehl,H. Mueller-Huesmann, G. Klautke, J. von der Gruen, D. Beutner, J. Buentzel, C-J. Busch,B. F. Tamaskovics,

ANNALS OF ONCOLOGYno. 7 (2022): S854-S854

引用0浏览0引用

EP04.02-005 First Comprehensive Lung Cancer Long-Term Survivorship Program - Late Toxicities and Overall Survival

J.-P.H. Exner, S. Nadjm,R. Hepp de los Rios,M. Metzenmacher,A.-C. Hoffmann,T.C. Gauler, C. Aigner, G. Stamatis,F. Oezkan,C. Schulte, K. Darwiche, C. Taube,

Journal of Thoracic Oncologyno. 9 (2022)

引用0浏览0引用

Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLC

W. E. E. Eberhardt,C. Poettgen,T. C. Gauler,C. Schulte, G. Friedel,H. -G. Kopp,B. Fischer, H. Schmidberger,M. Kimmich, W. Budach,S. Cordes,M. Metzenmacher,

Journal of Thoracic Oncologyno. 9 (2022): S65-S65

引用0浏览0引用

EP04.01-016 First Comprehensive Lung Cancer Long-Term Survivorship Analysis - Late Toxicities and Overall Survival

J.-P. Exner, S. Nadjm,R. Hepp de los Rios,M. Metzenmacher,A.-C. Hoffmann,T.C. Gauler, C. Aigner, G. Stamatis,F. Oezkan,C. Schulte, K. Darwiche, C. Taube,

Journal of Thoracic Oncology（2022）

引用0浏览0引用

HANNA: Real-world data of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN), including first-line population, treated with nivolumab in Germany

C. Langer,E. von der Heyde, D. A. Hahn, B. Kubuschok, U. Bockmuehl,H. Mueller-Huesmann, G. Klautke,J. von der Gruen, D. Beutner, J. Buentzel,C-J. Busch,B. F. Tamaskovics,

Annals of Oncologyno. 7 (2022): S854-S854

引用2浏览0引用

First Comprehensive Lung Cancer Long-Term Survivorship Program - Late Toxicities and Overall Survival

J. P. H. Exner, S. Nadjm,R. Hepp De Los Rios,M. Metzenmacher,A. C. Hoffmann,T. C. Gauler, C. Aigner, G. Stamatis,F. Oezkan,C. Schulte, K. Darwiche, C. Taube,

JOURNAL OF THORACIC ONCOLOGY（2022）

引用0浏览0引用

Systemic inflammatory response parameters as prognostic markers in patients with recurrent or metastatic head and neck cancer treated with immunotherapy

M. Pogorzelski, F. Lauri, T. Hilser,J. Hense, S. C. Ting,B. Kansy, K. Laue,T. C. Gauler, M. Stuschke, K. W. Schmid,S. Lang, V Gruenwald,

ONCOLOGY RESEARCH AND TREATMENT（2021）

引用0浏览0引用

Influence of a prospective Gating on the Target Volumes in the Planning of definitive Radiotherapy for Patients with locally advanced Lung Cancer

C. Poettgen, M. Guberina, F. Indenkaempen, A. Fluehs,T. C. Gauler, M. Stuschke

STRAHLENTHERAPIE UND ONKOLOGIEno. SUPnan (2019): S74-S74

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn